gallocatechol has been researched along with cytochrome c-t in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henkel, JS; Jung, HK; Kim, J; Kim, KS; Kim, MH; Kim, SH; Koh, SH; Kwon, H; Park, Y; Song, CW; Yu, HJ | 1 |
1 other study(ies) available for gallocatechol and cytochrome c-t
Article | Year |
---|---|
Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3.
Topics: Animals; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Catechin; Cell Differentiation; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Nerve Growth Factor; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats | 2003 |